# A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

> **NCT07154914** · — · NOT_YET_RECRUITING · sponsor: **Anhui Medical University** · enrollment: 396 (estimated)

## Conditions studied

- Metastatic Hormone-Sensitive Prostate Cance

## Interventions

- **DRUG:** Abiraterone + ADT

## Key facts

- **NCT ID:** NCT07154914
- **Lead sponsor:** Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 396 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07154914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07154914, "A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07154914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*